- JP-listed companies
- Cash flow
(3417) Cash flow
Market cap
¥14.8B
P/E ratio
10.7x
Oki Healthcare Holdings manages a pharmaceutical group of eight companies that manufacture and sell medicines and related products for the healthcare industry.
| 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 380 | 356 | 366 | 371 | 401 | 396 | 381 | 375 | 377 | 387 | 450 |
| Cash from operations | 1,264 | -636 | 5,593 | 2,730 | -901 | -4,273 | 1,309 | 96 | 7,548 | -9,184 | -1,415 |
| Capital expenditures | -163 | -160 | -316 | -402 | -413 | -128 | -91 | -234 | -277 | -2,842 | -1,321 |
| Cash from investing | -104 | -207 | -1,473 | -459 | -461 | 710 | 68 | -291 | -496 | -3,132 | -671 |
| Payments for dividends | -151 | -166 | -182 | -236 | -250 | -260 | -274 | -292 | -304 | -327 | -353 |
| Repurchases of common stock | - | - | -48 | - | -186 | - | - | - | -150 | - | - |
| Proceeds from issuance of term debt, net | 1,000 | 250 | 100 | 480 | 300 | 100 | 300 | 1,950 | - | 1,000 | - |
| Repayments of term debt | -1,031 | -1,068 | -914 | -1,088 | -405 | -426 | -138 | -272 | -351 | -321 | -1,436 |
| Cash from financing | -9 | -11 | -1,654 | -1,259 | -608 | 2,361 | -1,403 | 681 | -1,996 | 6,888 | 1,420 |